Company Analysis

Utah Medical Products, Inc. (UTMD)

Nasdaq: UTMD · Surgical & Medical Instruments & Apparatus · Midvale, UT · filing with the SEC since 1994
Grade5.9
◀ Past 5.9● Present 6.9▶ Future 4.7
The companyfiscal 2025, as filed
Revenue$38.5M-5.8%
Net income$11.3M-18.7%
Earnings per share$3.48-12.1%
Operating cash flow$14.7M-0.9%
Cash$85.8M+3.4%
Debt$0.00
Shareholders’ equity$119M+1.6%
Shares, diluted3,240,000-7.5%
Return on equity9.5%
The recordfrom its filings
Filings in 202626
Newest filingNov 3 · 8-K
Annual reportMar 27, 2026
Quarterly reportAug 12, 2026
Next report due10-Q by Nov 14
Insider sales, 12 months$0.00
Insider buys, 12 months$100,000
Patents granted41
Filer categoryNon-accelerated filer<br>Smaller reporting company
Trailing twelve months to Jun 2026Revenue $36.1MNet income $10.5MCash from operations $11.8Mthe four newest filed quarters added
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
Revenue and net income by fiscal yearRevenueNet income
16171819202122232425
As filed, in USD. Nothing here is a forecast.

News

Nov 3, 2026 · SEC EDGAR · Form 8-K
Current report
Open the filing on sec.gov
Oct 29, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Oct 22, 2026 · SEC EDGAR · Form 8-K
Results released
Open the filing on sec.gov
Sep 24, 2026 · SEC EDGAR · Form SC TO-I
Issuer tender offer
Open the filing on sec.gov
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.
SI Assistanton UTMD · research, not advice